Literature DB >> 2085770

Effects of lidocaine injection in the interpositus nucleus and red nucleus on conditioned behavioral and neuronal responses.

P F Chapman1, J E Steinmetz, L L Sears, R F Thompson.   

Abstract

The role of the cerebellum and the red nucleus in the conditioned eyeblink response was assessed, using a combination of reversible lesions and multiple-unit extracellular recording in the awake, behaving rabbit. Lesion, recording, and stimulation experiments have indicated that both of these structures are involved in the performance of learned skeletal muscle responses. The present study sought to distinguish the relative contributions of the interpositus nucleus and the red nucleus to the expression of the learned response by recording behavior-related multiple unit activity in one structure while reversibly inactivating the other via injections of local anesthetic. Results indicate that inactivating either the interpositus or the red nucleus temporarily abolishes the learned eyeblink response. Injection of lidocaine into the interpositus also abolishes the neuronal unit model of the conditioned response in the red nucleus, while injection into the red nucleus does not affect the model in the interpositus. These results are consistent with the hypothesis that the red nucleus acts as a relay for motor commands from the cerebellum, and that the plasticity that generates conditioned responses occurs in the cerebellum or an afferent structure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085770     DOI: 10.1016/0006-8993(90)90351-b

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Developmental changes in eyeblink conditioning and neuronal activity in the pontine nuclei.

Authors:  John H Freeman; Adam S Muckler
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

2.  Multiple sites of extinction for a single learned response.

Authors:  Brian E Kalmbach; Michael D Mauk
Journal:  J Neurophysiol       Date:  2011-09-21       Impact factor: 2.714

3.  Cerebellar cortex lesions prevent acquisition of conditioned eyelid responses.

Authors:  K S Garcia; P M Steele; M D Mauk
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

4.  Molecular evidence for two-stage learning and partial laterality in eyeblink conditioning of mice.

Authors:  Jin-Sung Park; Takashi Onodera; Shin-ichi Nishimura; Richard F Thompson; Shigeyoshi Itohara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-28       Impact factor: 11.205

5.  Anatomical evidence for the involvement of medial cerebellar output from the interpositus nuclei in cognitive functions.

Authors:  Xiaofeng Lu; Shigehiro Miyachi; Masahiko Takada
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

6.  Associative plasticity in the medial auditory thalamus and cerebellar interpositus nucleus during eyeblink conditioning.

Authors:  Hunter E Halverson; Inah Lee; John H Freeman
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

7.  Cerebellar inhibitory output shapes the temporal dynamics of its somatosensory inferior olivary input.

Authors:  Roni Hogri; Eyal Segalis; Matti Mintz
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

8.  Intracerebellar cannabinoid administration impairs delay but not trace eyeblink conditioning.

Authors:  Adam B Steinmetz; John H Freeman
Journal:  Behav Brain Res       Date:  2019-09-24       Impact factor: 3.332

9.  Blockade of GABAA receptors in the interpositus nucleus modulates expression of conditioned excitation but not conditioned inhibition of the eyeblink response.

Authors:  Brian C Nolan; Daniel A Nicholson; John H Freeman
Journal:  Integr Physiol Behav Sci       Date:  2002 Oct-Dec

10.  The temporary inactivation of the red nucleus affects performance of both conditioned and unconditioned nictitating membrane responses in the rabbit.

Authors:  V Bracha; S L Stewart; J R Bloedel
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.